BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15510008)

  • 1. Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer.
    Yoo GH; Piechocki MP; Oliver J; Lonardo F; Zumstein L; Lin HS; Kim H; Shibuya TY; Shehadeh N; Ensley JF
    Laryngoscope; 2004 Nov; 114(11):1871-9. PubMed ID: 15510008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma.
    Yoo GH; Subramanian G; Boinpally RR; Iskander A; Shehadeh N; Oliver J; Ezzat W; Piechocki MP; Ensley JF; Lin HS; Shibuya TY; Polin L; Parchment RE
    Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):418-29. PubMed ID: 15897421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
    Yoo GH; Piechocki MP; Ensley JF; Nguyen T; Oliver J; Meng H; Kewson D; Shibuya TY; Lonardo F; Tainsky MA
    Clin Cancer Res; 2002 Dec; 8(12):3910-21. PubMed ID: 12473607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMS-275183-induced gene expression patterns in head and neck carcinoma.
    Yoo GH; Tran VR; Lemonnier LA; Ezzat WH; Subramanian G; Piechocki MP; Ensley JF; Lonardo F; Kim H; Lin HS
    Am J Otolaryngol; 2007; 28(5):309-15. PubMed ID: 17826531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XRP6258-induced gene expression patterns in head and neck cancer carcinoma.
    Yoo GH; Kafri Z; Ensley JF; Lonardo F; Kim H; Folbe AJ; Won J; Stevens T; Lin HS
    Laryngoscope; 2010 Jun; 120(6):1114-9. PubMed ID: 20513026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral delivery of docetaxel enhances antitumor activity of Ad-p53 in murine head and neck cancer xenograft model.
    Yoo GH; Subramanian G; Ezzat WH; Tulunay OE; Tran VR; Lonardo F; Ensley JF; Kim H; Won J; Stevens T; Zumstein LA; Lin HS
    Am J Otolaryngol; 2010; 31(2):78-83. PubMed ID: 20015717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
    Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
    Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
    Yoo GH; Subramanian G; Piechocki MP; Ensley JF; Kucuk O; Tulunay OE; Lonardo F; Kim H; Won J; Stevens T; Lin HS
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):735-42. PubMed ID: 18645124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes.
    Yoo GH; Washington J; Oliver J; Piechocki M; Kim H; Foster-Nora J; Shibuya TY; Wilson DR; Ensley JF
    Cancer; 2002 Jan; 94(1):159-66. PubMed ID: 11815972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.
    Ndoye A; Dolivet G; Høgset A; Leroux A; Fifre A; Erbacher P; Berg K; Behr JP; Guillemin F; Merlin JL
    Mol Ther; 2006 Jun; 13(6):1156-62. PubMed ID: 16564229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
    Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW
    Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
    Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma.
    Saito H; Ando S; Morishita N; Lee KM; Dator D; Dy D; Shigemura K; Adhim Z; Nibu K; Fujisawa M; Shirakawa T
    Anticancer Res; 2014 Jul; 34(7):3365-70. PubMed ID: 24982341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D
    BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
    Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.
    Clayman GL; el-Naggar AK; Lippman SM; Henderson YC; Frederick M; Merritt JA; Zumstein LA; Timmons TM; Liu TJ; Ginsberg L; Roth JA; Hong WK; Bruso P; Goepfert H
    J Clin Oncol; 1998 Jun; 16(6):2221-32. PubMed ID: 9626224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines.
    Koh TY; Park SW; Park KH; Lee SG; Seol JG; Lee DW; Lee CT; Heo DS; Kim KH; Sung MW
    Head Neck; 2003 Jan; 25(1):44-9. PubMed ID: 12478543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant exposure of ovarian cancer cells to docetaxel, CPT-11 or SN-38 and adenovirus-mediated p53 gene therapy.
    Miettinen S; Ylikomi T
    Anticancer Drugs; 2009 Aug; 20(7):589-600. PubMed ID: 19491654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.